| 1 |
Zeng W, Mao R, Zhang Z, Chen X. Combination Therapies for Advanced Biliary Tract Cancer. J Clin Transl Hepatol 2023;11:490-501. [PMID: 36643047 DOI: 10.14218/JCTH.2022.00277] [Reference Citation Analysis]
|
| 2 |
Inoue T, Yoneda M. Recent Updates on Local Ablative Therapy Combined with Chemotherapy for Extrahepatic Cholangiocarcinoma: Photodynamic Therapy and Radiofrequency Ablation. Curr Oncol 2023;30:2159-68. [PMID: 36826127 DOI: 10.3390/curroncol30020166] [Reference Citation Analysis]
|
| 3 |
Tchelebi LT, Jethwa KR, Levy AT, Anker CJ, Kennedy T, Grodstein E, Hallemeier CL, Jabbour SK, Kim E, Kumar R, Lee P, Small W Jr, Williams VM, Sharma N, Russo S. American Radium Society (ARS) Appropriate Use Criteria (AUC) for Extrahepatic Cholangiocarcinoma. Am J Clin Oncol 2023;46:73-84. [PMID: 36534388 DOI: 10.1097/COC.0000000000000969] [Reference Citation Analysis]
|
| 4 |
Denzer U, Dechêne A. Endoskopisch gesteuerte Diagnostik und Therapie von Cholangiokarzinomen. Gastroenterologie 2023. [DOI: 10.1007/s11377-022-00667-y] [Reference Citation Analysis]
|
| 5 |
Liang J, Jiang Y, Abboud Y, Gaddam S. Role of Endoscopy in Management of Upper Gastrointestinal Cancers. Diseases 2022;11:3. [PMID: 36648868 DOI: 10.3390/diseases11010003] [Reference Citation Analysis]
|
| 6 |
Oh D, Chong J, Song TJ, Park DH, Lee SS, Seo DW, Lee SK, Kim MH. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction. J Gastroenterol Hepatol 2022;37:2083-90. [PMID: 35869749 DOI: 10.1111/jgh.15967] [Reference Citation Analysis]
|
| 7 |
Canakis A, Kahaleh M. Endoscopic palliation of malignant biliary obstruction. World J Gastrointest Endosc 2022; 14(10): 581-596 [DOI: 10.4253/wjge.v14.i10.581] [Reference Citation Analysis]
|
| 8 |
Prinz C, Frese R, Grams M, Fehring L. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma. Genes (Basel) 2022;13:1479. [PMID: 36011390 DOI: 10.3390/genes13081479] [Reference Citation Analysis]
|
| 9 |
Prinz C, Fehring L, Frese R. MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions. Cells 2022;11:2374. [DOI: 10.3390/cells11152374] [Reference Citation Analysis]
|
| 10 |
Zimpel C, Mitzlaff K, Jasper N, Marquardt JU. Aktuelle Studien und Evidenz zum Cholangiokarzinom. Zentralbl Chir 2022;147:389-397. [DOI: 10.1055/a-1844-0267] [Reference Citation Analysis]
|
| 11 |
Jarosova J, Macinga P, Krupickova L, Fialova M, Hujova A, Mares J, Urban O, Hajer J, Spicak J, Striz I, Hucl T. Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma. Biomedicines 2022;10:1331. [DOI: 10.3390/biomedicines10061331] [Reference Citation Analysis]
|
| 12 |
Kouladouros K, Hirth M. Palliative endoskopische Therapie bei Klatskin-Tumoren. Onkologie up2date 2022;4:161-178. [DOI: 10.1055/a-1756-1159] [Reference Citation Analysis]
|
| 13 |
Kang H, Kim EJ, Kim YS. Intraductal Radiofrequency Ablation as a Palliative Treatment for Advanced Malignant Hilar Biliary Obstruction. Korean J Med 2022;97:164-170. [DOI: 10.3904/kjm.2022.97.3.164] [Reference Citation Analysis]
|
| 14 |
Song S, Gong S, Lei T, Tian H, Lu T, Lei C, Jin H, Yang W, Yang K, Guo T. Comparative efficacy and safety of local palliative therapeutics for unresectable malignant biliary obstruction: a Bayesian network meta-analysis. Expert Rev Gastroenterol Hepatol 2022;16:555-67. [PMID: 35639826 DOI: 10.1080/17474124.2022.2085090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Inoue T, Naitoh I, Kitano R, Ibusuki M, Kobayashi Y, Sumida Y, Nakade Y, Ito K, Yoneda M. Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma. Current Oncology 2022;29:2240-51. [DOI: 10.3390/curroncol29040182] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 16 |
Song S, Jin H, Cheng Q, Gong S, Lv K, Lei T, Tian H, Li X, Lei C, Yang W, Yang K, Guo T. Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials. Surg Endosc 2022. [PMID: 35296949 DOI: 10.1007/s00464-022-09181-2] [Reference Citation Analysis]
|
| 17 |
Iwasaki E. Inoperable duodenal ampullary carcinoma: Can endoscopic radiofrequency ablation therapy be a promising palliative treatment in the future? Dig Endosc 2022;34:466-8. [PMID: 34994007 DOI: 10.1111/den.14212] [Reference Citation Analysis]
|
| 18 |
Inoue T, Yoneda M. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction. Dig Endosc 2022;34:345-58. [PMID: 34107114 DOI: 10.1111/den.14059] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 19 |
Kang H, Han SY, Cho JH, Kim EJ, Kim DU, Yang JK, Jeon S, Park G, Lee TH. Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial. J Hepatobiliary Pancreat Sci 2021. [PMID: 34800357 DOI: 10.1002/jhbp.1082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Cho JH, Jang SI, Do MY, Lee DK. [Recent Updates on Endoscopic Retrograde Cholangiography-guided Intraductal Radiofrequency Ablation for Malignant Biliary Stricture]. Korean J Gastroenterol 2021;78:205-12. [PMID: 34697274 DOI: 10.4166/kjg.2021.121] [Reference Citation Analysis]
|
| 21 |
Kouladouros K, Hirth M. Palliative endoskopische Therapie bei Klatskin-Tumoren. Allgemein- und Viszeralchirurgie up2date 2021;15:307-322. [DOI: 10.1055/a-1317-3509] [Reference Citation Analysis]
|
| 22 |
Do MY, Cho JH, Jang SI, Lee DK. A review of the recent advances in endoscopic retrograde cholangiography-guided intraductal radiofrequency ablation for malignant biliary strictures. Int J Gastrointest Interv 2021;10:90-5. [DOI: 10.18528/ijgii210033] [Reference Citation Analysis]
|
| 23 |
Guardado NV, Llorente K, Blondeau B. Evaluation and Management of Malignant Biliary Obstruction. Surg Oncol Clin N Am 2021;30:491-503. [PMID: 34053664 DOI: 10.1016/j.soc.2021.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Pereira P, Santos AL, Morais R, Vilas-Boas F, Rodrigues-Pinto E, Santos-Antunes J, Macedo G. Endoscopic radiofrequency ablation for palliative treatment of hilar cholangiocarcinoma. VideoGIE 2021;6:195-8. [PMID: 33898902 DOI: 10.1016/j.vgie.2020.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Weismüller TJ. Role of Intraductal RFA: A Novel Tool in the Palliative Care of Perihilar Cholangiocarcinoma. Visc Med 2021;37:39-47. [PMID: 33718482 DOI: 10.1159/000513970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Ogura T. Novel Endoscopic Focal Therapy for Pancreatic Cancer and Cholangiocarcinoma. Management of Pancreatic Cancer and Cholangiocarcinoma 2021. [DOI: 10.1007/978-981-16-2870-2_22] [Reference Citation Analysis]
|
| 27 |
Gaddam S, Coté GA. The importance of the "endoscopic oncologist" in the treatment of nonoperable cholangiocarcinoma. Gastrointest Endosc 2020;92:1213-5. [PMID: 33236993 DOI: 10.1016/j.gie.2020.06.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
